Louvet, C., André, T., Gamelin, E., Hebbar, M., Mabro, M., Bennamoun, M., . . . de Gramont, A. (2010). Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer. Hindawi Publishing Corporation.
Chicago ZitierstilLouvet, C., T. André, E. Gamelin, M. Hebbar, M. Mabro, M. Bennamoun, H. Rassam, und A. de Gramont. Phase II Study of Biweekly Pemetrexed Plus Irinotecan As Second-Line Therapy for Metastatic Colorectal Cancer. Hindawi Publishing Corporation, 2010.
MLA ZitierstilLouvet, C., et al. Phase II Study of Biweekly Pemetrexed Plus Irinotecan As Second-Line Therapy for Metastatic Colorectal Cancer. Hindawi Publishing Corporation, 2010.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.